[Inhibitory effect of the polycation oligo-N-methylmorpholiniumpropylene oxide on development demonstrated on the model of metamorphosis of anurics in connection with subcellular distribution of lysosomal acidic phosphatase].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000135:Acid Phosphatase / Q000378:metabolism*; D000818:Animals; D001001:Anura; D001711:Biotransformation; D004789:Enzyme Activation; D005552:Forelimb / Q000187:drug effects; D006128:Growth / Q000187:drug effects; D002479:Inclusion Bodies; D008247:Lysosomes / Q000378:metabolism*; D008675:Metamorphosis, Biological / Q000187:drug effects*; D008954:Models, Biological; D009025:Morpholines / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D011108:Polymers / Q000494:pharmacology*; D013997:Time Factors
D009025:Morpholines; D011108:Polymers; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases
Die entwicklungshemmende Wirkung des Polykations Oligo-N-methylmorpholiniumpropylenoxid am Modell der Metamorphose von Anuren in Zusammenhang mit der subzellulären Verteilung der lysosomalen sauren Phosphatase.